Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 5/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93283 | 0.83 | NPSR1 (0.55) | NPSR1MEN1KMT2AHTTTHRB | |
| SCHEMBL23166166 | 0.82 | GPR35 (0.77) | GPR35MAPTALDH1A1LMNA | |
| SCHEMBL17400848 | 0.79 | GPR35 (0.74) | GPR35MEN1KMT2AALDH1A1LMNA | |
| SCHEMBL27923493 | 0.78 | MEN1 (0.73) | NPSR1MEN1KMT2AHTTTHRB | |
| SCHEMBL24363890 | 0.78 | PRMT5 (0.51) | GPR35 | |
| SCHEMBL9613267 | 0.77 | NPC1 (0.64) | GPR35MEN1KMT2AMAPTKDM4E | |
| SCHEMBL31598567 | 0.77 | NPSR1 (0.46) | NPSR1MEN1KMT2AHTTTHRB | |
| SCHEMBL849875 | 0.76 | MEN1 (0.77) | NPSR1MEN1KMT2AHTTTHRB | |
| SCHEMBL18795896 | 0.76 | ALDH1A1 (0.70) | GPR35NPSR1MEN1KMT2AHTT | |
| SCHEMBL7720238 | 0.74 | NPSR1 (0.52) | NPSR1MEN1KMT2AHTTTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119948005-A | Method for synthesizing methoxy substituted benzaldehyde compound | 先正达农作物保护股份公司 | 2025-05-06 | — | — | CN | claimed |
| CN-109705022-A | A kind of preparation method of aromatic amine intermediate | 上海彩迩文生化科技有限公司 | 2019-05-03 | — | — | CN | claimed |
| CN-106458943-A | Synthesis of vortioxetine via (2, 4-dimethylphenyl) (2-iodophenyl) sulfane intermediate | 斯洛文尼亚莱柯制药股份有限公司 | 2017-02-22 | — | — | CN | claimed |
| US-12534547-B2 | Resin particle | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-4488763-B1 | TONER SET, ELECTROSTATIC IMAGE DEVELOPER SET, TONER CARTRIDGE SET, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, IMAGE FORMING METHOD, AND PRINTED MATERIAL | FUJIFILM BUSINESS INNOVATION CORP (JP) | 2025-12-10 | — | — | EP | disclosed |
| EP-4625050-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER SET, ELECTROSTATIC CHARGE IMAGE DEVELOPER SET, TONER CARTRIDGE SET, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM Business Innovation Corp. (JP) | 2025-10-01 | — | — | EP | disclosed |
| US-20250298332-A1 | ELECTROSTATIC CHARGE IMAGE DEVELOPING TONER SET, ELECTROSTATIC CHARGE IMAGE DEVELOPER SET, TONER CARTRIDGE SET, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250291269-A1 | ELECTROSTATIC IMAGE DEVELOPING TONER, ELECTROSTATIC IMAGE DEVELOPER, TONER CARTRIDGE, PROCESS CARTRIDGE, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2025-09-18 | — | — | US | disclosed |
| EP-4608796-A1 | PROCESS FOR THE SYNTHESIS OF METHOXY SUBSTITUTED BENZALDEHYDE COMPOUNDS | Syngenta Crop Protection AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-20250250394-A1 | DIELECTRIC POLYMER MATERIALS WITH COLORATION AND DEVICES USING THEM | USINVEST LLC | 2025-08-07 | — | — | US | disclosed |
| EP-3965738-B1 | METHOD FOR PRODUCTION OF LIPOSOMES | UNIV DO MINHO (PT) | 2025-08-06 | — | — | EP | disclosed |
| CN-110214135-A | Indanyl Aminopyrazine basic ring propanecarboxylic acid, medical composition and its use | 勃林格殷格翰国际有限公司 | 2019-09-06 | — | — | CN | disclosed |
| CN-109705022-A | A kind of preparation method of aromatic amine intermediate | 上海彩迩文生化科技有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-106458943-B | Synthesis of vortioxetine via (2, 4-dimethylphenyl) (2-iodophenyl) sulfane intermediate | 斯洛文尼亚莱柯制药股份有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-109476668-A | For treating 6,7- dihydro -4H- pyrazolo [1,5-a] pyrazine and 6,7- dihydro -4H- triazol [1,5-a] pyrazine compound of infectious diseases | 豪夫迈·罗氏有限公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-109153682-A | For treating the new pyrazine compound with oxygen, sulphur and nitrogen linker of infectious diseases | 豪夫迈·罗氏有限公司 | 2019-01-04 | — | — | CN | disclosed |
| CN-105121433-B | Antiviral compound, its pharmaceutically acceptable salt or optical isomer, the method for preparing them and the pharmaceutical composition for being used to prevent or treat viral disease for containing the same as active ingredient | 韩国化学研究院 | 2018-01-23 | — | — | CN | disclosed |
| CN-107072993-A | Medicine containing sodium dependence phosphate transporter inhibitor | 中外制药株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-106458943-A | Synthesis of vortioxetine via (2, 4-dimethylphenyl) (2-iodophenyl) sulfane intermediate | 斯洛文尼亚莱柯制药股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-105121433-A | Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient | KOREA RES INST CHEM TECH | 2015-12-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534547-B2 | Resin particle | NR2E3, RARA, IK | GPR35 1433/4885NPSR1 2342/4885MEN1 4442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.